Browsing by Author "Marsden, Peter"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Open Access Clarifying the absence of evidence regarding human health risks to microplastic particles in drinking-water: High quality robust data wanted(Elsevier, 2020-10-07) Gouin, Todd; Cunliffe, David; De France, J.; Fawell, John; Jarvis, Peter; Koelmans, A. A. (Bart); Marsden, Peter; Testai, Emanuela E.; Asami, Mari; Bevan, Ruth; Carrier, R.; Cotruvo, Joseph; Eckhardt, Alexander; Ong, Choon NamIn a recently published article, Leslie and Depledge (2020) raise concerns regarding statements on the risk that microplastic particles represent to human health and which have been attributed to reports published by both the Science Academies’ Group, Science Advice for Policy (SAPEA) (part of the European Commission’s Science Advice Mechanism) and the World Health Organization (WHO) (SAPEA. Science Advice for Policy by European Academies, 2019, WHO, 2019). Leslie and Depledge (2020), for instance, suggest that WHO (2019) conclude that there is ‘no evidence to indicate a human health concern.’ This statement, taken out of context from the WHO report (WHO, 2019), is then used to imply that the WHO conclude there is ‘no risk’ related to the exposure of microplastic particles (Leslie and Depledge, 2020). While, Leslie and Depledge (2020) highlight the importance of debate and systematic assessment of claims related to the assessment of risk, observations that we agree are important to highlight, there are a number of points raised in the article that require clarification.Item Open Access Meeting report: risk assessment of tamiflu use under pandemic conditions(Nat Inst of Environ Health Sciences / The National Institute of Environmental Health Sciences (NIEHS), 2008-11-30T00:00:00Z) Singer, Andrew C.; Howard, Bruce M.; Johnson, Andrew C.; Knowles, Chris J.; Jackman, Simon; Accinelli, Cesare; Caracciolo, Anna Barra; Bernard, Ian; Bird, Stephen; Boucard, Tatiana; Boxall, Alistair; Brian, Jayne V.; Cartmell, Elise; Chubb, Chris; Churchley, J.; Costigan, Sandra; Crane, Mark; Dempsey, Michael J.; Dorrington, Bob; Ellor, Brian; Fick, Jerker; Holmes, John; Hutchinson, Tom; Karcher, Franz; Kelleher, Samuel L.; Marsden, Peter; Noone, Gerald; Nunn, Miles A.; Oxford, John; Rachwal, Tony; Roberts, Noel; Roberts, Mike; Sacca, Maria Ludovica; Sanders, Matthew; Straub, Jürg Oliver; Terry, Adrian; Thomas, Dean; Toovey, Stephen; Townsend, Rodney; Vouivoulis, Nikolaos; Watts, ChrisOn 3 October 2007, 40 participants with diverse expertise attended the workshop Tamiflu and the Environment: Implications of Use under Pandemic Conditions to assess the potential human health impact and environmental hazards associated with use of Tamiflu during an influenza pandemic. Based on the identification and risk-ranking of knowledge gaps, the consensus was that oseltamivir ethylester-phosphate (OE-P) and oseltamivir carboxylate (OC) were unlikely to pose an ecotoxicologic hazard to freshwater organisms. OC in river water might hasten the generation of OC-resistance in wildfowl, but this possibility seems less likely than the potential disruption that could be posed by OC and other pharmaceuticals to the operation of sewage treatment plants. The work-group members agreed on the following research priorities: a) available data on the ecotoxicology of OE-P and OC should be published; b) risk should be assessed for OC-contaminated river water generating OC-resistant viruses in wildfowl; c) sewage treatment plant functioning due to microbial inhibition by neuraminidase inhibitors and other antimicrobials used during a pandemic should be investigated: and e realistic worst-case exposure scenarios should be developed. Additional modeling would be useful to identify localized areas within river catchments that might be prone to high pharmaceutical concentrations in sewage treatment plant effluent. Ongoing seasonal use of Tamiflu in Japan offers opportunities for researchers to assess how much OC enters and persists in the aquatic environment.